Derazantinib (ARQ 087) in advanced or inoperable FGFR2 gene fusion-positive intrahepatic cholangiocarcinoma - Mazzaferro, V; El-Rayes, B F; Droz, Dit Busset M (Br J Cancer, 2019)
et al.